Stable coronary artery disease, quality of life, and atrial fibrillation. AVANCE study. A national survey

被引：0
|
作者：
Garcia-Moll Marimon, X. [1 ]
Borras, X. [1 ]
Gomez-Doblas, J. J. [2 ]
Zapata, A. [3 ]
Artigas, R. [3 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Dept Cardiol, Barcelona, Spain
[2] Univ Hosp Virgen de la Victoria, Dept Cardiol, Malaga, Spain
[3] Menarini Spain Labs, Badalona, Spain
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4623
引用
收藏
页码：832 / 832
页数：1
相关论文
共 50 条
  • [1] Heart rate and quality of life in stable angina patients. AVANCE study. A national survey
    Garcia-Moll Marimon, X.
    Borras Perez, X.
    Gomez Doblas, J. J.
    Zapata, A.
    Artigas, R.
    EUROPEAN HEART JOURNAL, 2014, 35 : 491 - 491
  • [2] Atrial Fibrillation and Stable Coronary Artery Disease
    Lip, Gregory Y. H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (22): : 2159 - 2161
  • [3] Edoxaban for Atrial Fibrillation and Stable Coronary Artery Disease
    Gremmel, Thomas
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (08): : 826 - 827
  • [4] Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry
    Fauchier, Laurent
    Greenlaw, Nicola
    Ferrari, Roberto
    Ford, Ian
    Fox, Kim M.
    Tardif, Jean-Claude
    Tendera, Michal
    Steg, Ph. Gabriel
    PLOS ONE, 2015, 10 (04):
  • [5] Intermedin in Stable Coronary Artery Disease Patients with Atrial Fibrillation
    Lin, Shi
    Li, Pengyang
    Wang, Bin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C87 - C87
  • [6] Contribution of good control of cardiovascular risk factors or optimal medical treatment on quality of life in patients with stable angina. The AVANCE study. A national survey
    Garcia-Moll Marimon, X.
    Borras, X.
    Gomez Doblas, J. J.
    Zapata, A.
    Artigas, R.
    EUROPEAN HEART JOURNAL, 2014, 35 : 490 - 490
  • [7] Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
    Cho, Min Soo
    Kang, Do-Yoon
    Ahn, Jung-Min
    Yun, Sung-Cheol
    Oh, Yong-Seog
    Lee, Chang Hoon
    Choi, Eue-Keun
    Lee, Ji Hyun
    Kwon, Chang Hee
    Park, Gyung-Min
    Choi, Hyung Oh
    Park, Kyoung-Ha
    Park, Kyoung-Min
    Hwang, Jongmin
    Yoo, Ki-Dong
    Cho, Young-Rak
    Kim, Ji Hyun
    Hwang, Ki Won
    Jin, Eun-Sun
    Kwon, Osung
    Kim, Ki-Hun
    Park, Seung-Jung
    Park, Duk-Woo
    Nam, Gi-Byoung
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (22): : 2075 - 2086
  • [8] The Clinical Features of Patients with Stable Coronary Artery Disease and Atrial Fibrillation
    Zhang, Kuo
    Wang, Wenyao
    Yuan, Xun
    Guo, Yang
    Yang, Min
    Mu, Mu
    Tang, Yida
    CARDIOLOGY, 2014, 129 : 23 - 23
  • [9] Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. Data from the international CLARIFY registry
    Fauchier, L.
    Greenlaw, N.
    Ferrari, R.
    Ford, I.
    Fox, K.
    Tardif, J. C.
    Tendera, M.
    Steg, P. G.
    EUROPEAN HEART JOURNAL, 2013, 34 : 97 - 97
  • [10] The utility of delta troponin in diagnosing significant coronary artery disease in patients with symptomatic atrial fibrillation.
    Oxenford, Cassie
    Fryar, James
    Pelecanos, Anita
    O'Rourke, Peter
    Tan, Christopher
    Alghamry, Alaa
    CORONARY ARTERY DISEASE, 2023, 34 (03) : 195 - 201
12345